|
| No. of patients | (%) |
| Total | 69 | 100.0 |
| Tumor stage |
|
|
| IIa | 3 | 4.3 |
| IIb | 2 | 2.9 |
| IIIa | 14 | 20.3 |
| IIIb | 50 | 72.5 |
| Histology |
|
|
| Adenocarcinoma | 23 | 33.3 |
| Squamous | 40 | 58.0 |
| Others | 5 | 7.3 |
| None | 1 | 1.4 |
| Sex |
|
|
| Male | 58 | 84.1 |
| Female | 11 | 15.9 |
| Chemotherapy |
|
|
| None | 18 | 26.1 |
| Sequential | 9 | 13.0 |
| Concurrent | 35 | 50.7 |
| Concurrent + sequential | 6 | 8.8 |
| Unknown | 1 | 1.4 |
| Age |
|
|
| 45 - 54 | 6 | 8.8 |
| 55 - 64 | 19 | 27.5 |
| 65 - 74 | 28 | 40.6 |
| ³75 | 16 | 23.1 |
| Mean | 67 |
|
| SD | 9 |
|